Aimei Health Technology (NASDAQ:AFJK) Trading Up 11% – What’s Next?

Aimei Health Technology Co., Ltd. (NASDAQ:AFJK) traded up 11% on Tuesday . The company traded as high as $84.00 and last traded at $79.50. 44,958 shares changed hands during mid-day trading, a decline of 56% from the average session volume of 102,480 shares. The stock had previously closed at $71.63.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Aimei Health Technology in a research note on Monday, December 29th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock presently has a consensus rating of “Sell”.

Aimei Health Technology Stock Down 13.0%

The company has a market capitalization of $410.10 million, a price-to-earnings ratio of 319.11 and a beta of -3.70. The business has a 50-day moving average price of $30.17 and a 200-day moving average price of $17.82.

Aimei Health Technology (NASDAQ:AFJK) last released its quarterly earnings results on Tuesday, November 18th. The company reported $0.06 earnings per share for the quarter.

Hedge Funds Weigh In On Aimei Health Technology

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Wellspring Financial Advisors LLC acquired a new stake in Aimei Health Technology during the 2nd quarter valued at $133,000. Clear Street LLC grew its holdings in shares of Aimei Health Technology by 63.8% during the second quarter. Clear Street LLC now owns 39,525 shares of the company’s stock valued at $441,000 after buying an additional 15,399 shares in the last quarter. Clear Street Group Inc. acquired a new position in Aimei Health Technology during the third quarter valued at $691,000. Quarry LP lifted its stake in Aimei Health Technology by 6.4% in the 3rd quarter. Quarry LP now owns 167,081 shares of the company’s stock worth $1,891,000 after acquiring an additional 10,000 shares in the last quarter. Finally, Crossingbridge Advisors LLC acquired a new stake in Aimei Health Technology during the 2nd quarter worth about $2,147,000. Institutional investors and hedge funds own 45.58% of the company’s stock.

About Aimei Health Technology

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.